11/4
09:59 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI
9/8
09:58 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Denali Therapeutics (NASDAQ:DNLI) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
9/8
09:18 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI